Aquestive Therapeutics (AQST) Stock Forecast & Price Target

AQST$3.91+0.34 +9.52%
Drug Manufacturers - Specialty & GenericGrowth Stock
Compare
Market cap$491.44MEnterprise value$366.46MRevenue (TTM)$48.84MMarket position—

Score

61
Neutral
Value
57
Quality
32
Growth
94

Aquestive Therapeutics, Inc. price target

AQST
Low$10.00
Average$10.50
High$11.00
Upside vs current price+168.5%

The average target of $10.50 is +168.5% versus the current AQST price of $3.91.

Aquestive Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy2
Buy7
Hold0
Sell0
Strong sell0
ConsensusBuy

9 analysts cover AQST.

Aquestive Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Aquestive Therapeutics, Inc. keeps 2026 EPS $-0.47, 2027 EPS $-0.49, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-0.47$49.50M
2027$-0.49$67.91M

Is Aquestive Therapeutics, Inc. a buy or sell?

Of the 9 analysts covering Aquestive Therapeutics, Inc., 9 rate it a buy (2 strong buy and 7 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The AQST consensus label is Buy, beside 9 buy-side ratings and 0 sell-side ratings.

The average target of $10.50 implies +168.5% versus the current price of $3.91.

the Aquestive Therapeutics, Inc. closes with 9 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Aquestive Therapeutics, Inc. forecast

There is little daylight between AQST targets. Low $10.00, average $10.50, high $11.00.

From today's $3.91 print, the AQST average target is +168.5% away.

Most of the AQST coverage agrees: 9 of 9 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

AQST targets have eased: $10.00 in the last month against $10.50 over the last quarter.

AQST coverage is thin at 9 analysts, and one revision moves the average.

Aquestive Therapeutics, Inc. forecast questions

What is the AQST price target?

The published range for AQST is $10.00 to $11.00, with an average of $10.50. That average is +168.5% versus the current price of $3.91.

Is Aquestive Therapeutics, Inc. a buy or sell?

Of the 9 analysts covering Aquestive Therapeutics, Inc., 9 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for AQST is 9 on the buy side, 0 at hold, and 0 on the sell side.

What is the EPS estimate for Aquestive Therapeutics, Inc.?

Analyst EPS estimates for Aquestive Therapeutics, Inc.: 2026 $-0.47, 2027 $-0.49.

What is the revenue estimate for Aquestive Therapeutics, Inc.?

Analyst revenue estimates for Aquestive Therapeutics, Inc.: 2026 $49.50M, 2027 $67.91M.

How many analysts cover AQST?

9 analysts cover AQST. Their consensus on AQST is Buy, across those 9.

AQST price $3.91 +0.34 +9.52%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener